País: Irlanda
Idioma: inglés
Fuente: HPRA (Health Products Regulatory Authority)
ESCITALOPRAM OXALATE
PCO Manufacturing
N06AB10
ESCITALOPRAM OXALATE
5 Milligram
Film Coated Tablet
Product subject to prescription which may not be renewed (A)
Selective serotonin reuptake inhibitors
Authorised
2006-02-10
_ _ PACKAGE LEAFLET: INFORMATION FOR THE USER LEXAPRO ® 5 MG FILM-COATED TABLETS LEXAPRO ® 10 MG FILM-COATED TABLETS LEXAPRO ® 15 MG FILM-COATED TABLETS LEXAPRO ® 20 MG FILM-COATED TABLETS escitalopram READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet: 1. What Lexapro is and what it is used for 2. What you need to know before you take Lexapro 3. How to take Lexapro 4. Possible side effects 5. How to store Lexapro 6. Contents of the pack and other information 1. WHAT LEXAPRO IS AND WHAT IT IS USED FOR Lexapro contains the active substance escitalopram. Lexapro belongs to a group of antidepressants called selective serotonin reuptake inhibitors (SSRIs). These medicines act on the serotonin-system in the bra Leer el documento completo
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Lexapro 5mg Film-coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 5mg escitalopram (as oxalate). For the full list of excipients, see Section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet. _Product imported from the UK:_ Round, white biconvex tablet marked with ‘EK’ on one side. 4 CLINICAL PARTICULARS As per PA0805/002/001 5 PHARMACOLOGICAL PROPERTIES As per PA0805/002/001 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Microcrystalline cellulose Colloidal anhydrous silica Talc Crosarmellose sodium Magnesium Stearate Hypromellose Macrogol 400 Titanium dioxide (E171) 6.2 INCOMPATIBILITIES Not applicable. 6.3 SHELF LIFE The shelf life expiry date of this product is the date shown on the container and outer package of the product on the market in the country of origin. 6.4 SPECIAL PRECAUTIONS FOR STORAGE This medicinal product does not require any special storage conditions. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 11/02/2016_ _CRN 2172084_ _page number: 1_ 6.5 NATURE AND CONTENTS OF CONTAINER Blister packs of 28 tablets contained in an outer cardboard carton. 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL OF A USED MEDICINAL PRODUCT OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCT AND OTHER HANDLING OF THE PRODUCT No special requirements. 7 PARALLEL PRODUCT AUTHORISATION HOLDER PCO Manufacturing Unit 10, Ashbourne Business Park Rath Ashbourne Co. Meath Ireland 8 PARALLEL PRODUCT AUTHORISATION NUMBER PPA0465/129/003 9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 10 February 2006 Date of last renewal: 10 February 2011 10 DATE OF REVISION OF THE TEXT February 2016 Leer el documento completo